C.R. Bard (BCR)


C.R. Bard stock research in summary

crbard.com


Latest Obermatt Ranks

Country USA
Industry Health Care Equipment
Index D.J. US Medical Equipment, S&P 500
Size class X-Large

December 8, 2017. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()







 

Research History: C.R. Bard

STOCK RESEARCH SUMMARY 2014 2015 2016 2017
STOCK VALUE RANKS
10
13
32
17
STOCK GROWTH RANKS
81
48
29
37
STOCK SAFETY RANKS
73
60
68
69
COMBINED STOCK RANKS
60
28
38
46

Last update of Combined Rank: 8-Dec-2017

Historic C.R. Bard stock analysis based on the Obermatt Method. The higher the rank, the better is C.R. Bard in the corresponding investment strategy.


Value Metrics in Detail

VALUE METRICS 2014 2015 2016 2017
PRICE VS. REVENUES (P/S)
22
22
14
12
PRICE VS. PROFITS (P/E)
36
29
56
46
PRICE VS. CAPITAL (Market-to-Book)
1
1
1
7
DIVIDEND YIELD
45
46
50
50
CONSOLIDATED RANK: VALUE
10
13
32
17

Last update of Value Rank: 8-Dec-2017

C.R. Bard stock analysis in respect to important value ratios. The higher the rank, the lower the value ratio; except for dividend yield where the rank is higher the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2014 2015 2016 2017
REVENUE GROWTH
68
37
41
13
PROFIT GROWTH
71
44
27
37
STOCK RETURNS
54
62
59
70
CONSOLIDATED RANK: GROWTH
81
48
29
37

Financial reporting date of Growth Rank: 30-Sep-2017

C.R. Bard stock analysis in respect to important growth metrics. The higher the rank, the higher the growth and returns.


Safety Metrics in Detail

SAFETY METRICS 2014 2015 2016 2017
LEVERAGE
34
28
32
80
REFINANCING
17
LIQUIDITY
88
86
91
88
CONSOLIDATED RANK: SAFETY
73
60
68
69

Financial reporting date of Safety Rank: 13-Oct-2017

C.R. Bard stock analysis in respect ot important safety metrics. The higher the rank, the lower the leverage and the more cash is available to service the debt.

Stock analysis by the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety for C.R. Bard (BCR) from December 8, 2017.